BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 36013314)

  • 1. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm.
    Gaulin C; Kelemen K; Arana Yi C
    Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
    Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
    Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
    Bewersdorf JP; Ardasheva A; Podoltsev NA; Singh A; Biancon G; Halene S; Zeidan AM
    Blood Rev; 2019 Sep; 37():100587. PubMed ID: 31400824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
    Ziemann F; Metzeler KH
    Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
    Karner K; George TI; Patel JL
    Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with clonal hematopoiesis and interaction with marrow environment.
    Nannya Y
    J Bone Miner Metab; 2023 May; 41(3):380-387. PubMed ID: 36346484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Kunimoto H; Nakajima H
    Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Clonal Hematopoiesis.
    Steensma DP
    Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
    Todisco G; Moura PL; Hellström-Lindberg E
    Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis: Pre-cancer PLUS.
    Silver AJ; Jaiswal S
    Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
    Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
    Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity-induced inflammation exacerbates clonal hematopoiesis.
    Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.